South & Central America Microplate Reader Market Forecast to 2031 - Regional Analysis - by Type (Single-Mode Microplate Readers and Multi-Mode Microplate Readers), Application (Drug Discovery, Clinical Diagnostics, Genomics and Proteomics Research, and Others), and End User (Biotechnology and Pharmaceutical Companies, Hospital and Diagnostic Laboratories, and Research and Academic Institutes)

The  South & Central America microplate reader market was valued at US$ 24.69 million in 2023 and is expected to reach US$ 35.30 million by 2031; it is estimated to register a CAGR of 4.6% from 2023 to 2031.

Expanding Applications in Biopharmaceutical Research Boost South & Central America Microplate Reader Market

A microplate reader is a laboratory instrument utilized to measure chemical, biological, or physical reactions within the wells of a microplate. It detects optical signals generated from these reactions, allowing for the quantification of specific analytes in the sample. Pharmaceutical and biotechnology research depends on variety of instrumentation. In high-throughput screening (HTS) and drug discovery, microplate-based assays assess large numbers of samples. A microplate reader detects signals and quantifies key parameters efficiently. These readers can handle up to 3,456 samples in minutes, minimizing operational time and reducing reagent costs. This efficiency allows researchers to focus more on data analysis and generating actionable insights, making microplate readers essential for various biological and chemical assays. Various market players, including Agilent Technologies, Inc.; Molecular Devices, LLC; and BMG LABTECH, offer innovative microplate readers for HTS and drug discovery research applications. BMG LABTECH's advanced detection technologies, such as NanoBRET and TR-FRET, can be used in high-throughput drug screening. In August 2023, Lonza launched the Nebula Absorbance Reader to improve endotoxin and pyrogen testing. The Nebula Absorbance Reader serves as a high-performance replacement, providing comparable results as the company’s Nebula Multimode Reader. Designed to work seamlessly with Lonza reagents, the Nebula Absorbance Reader meets specifications for Lonza’s endotoxin assays, including the PYROGENT 5000 and Kinetic-QCL assays. It also supports readouts for monocyte activation tests, such as the PyroCell MAT System.

South & Central America Microplate Reader Market Overview

Brazil is a major destination for clinical trials. According to Clinical Trials Arena, in 2021, Brazil accounted for a 1.7% share of the global clinical trials activity. In July 2022, Boston CRO acquired Rio de Janeiro-based Instituto Brasil de Pesquisa Clinica (IBPClin), describing it as the first step toward adopting its decentralized clinical trial delivery model in Latin America. It claims to have conducted more than 160 industry-sponsored research studies, enrolling more than 7,000 participants across 12 Brazilian states. IBPClin is the largest research center on the South American continent. In March 2020, the Fiocruz Foundation built a new hospital center and invested in clinical trials with the World Health Organization (WHO). The new hospital will also host the solidarity clinical trial led by Fiocruz in Brazil. The initiative is implemented in 18 hospitals in 12 states of Brazil with the support of the Department of Science and Technology of the Ministry of Health and coordinated by INI/Fiocruz. Thus, initiatives taken for developing clinical trials and research activities in Brazil boost the growth of the microplate reader market.

South & Central America Microplate Reader Market Segmentation Analysis:

The  South & Central America microplate reader market is categorized into type, application, end user, and country.

Based on type, the  South & Central America microplate reader market is bifurcated into single-mode microplate readers and multi-mode microplate readers. The single-mode microplate readers segment held a larger  South & Central America microplate reader market share in 2023. Furthermore, the single-mode microplate readers segment is subcategorized into absorbance plate readers, fluorescence plate readers and luminescence plate readers. Additionally, the multi-mode microplate readers segment is subsegmented into filter-based readers, monochromator-based readers and hybrid readers.

In terms of application, the  South & Central America microplate reader market is segmented into drug discovery, clinical diagnostics, genomics and proteomics research, and others. The drug discovery segment held the largest  South & Central America microplate reader market share in 2023.

In terms of end user, the  South & Central America microplate reader market is categorized into biotechnology and pharmaceutical companies, hospital and diagnostic laboratories, and research and academic institutes. The biotechnology and pharmaceutical companies segment held the largest  South & Central America microplate reader market share in 2023.

By country, the  South & Central America microplate reader market is segmented into Brazil, Argentina, and the Rest of  South & Central America. South Africa dominated the  South & Central America microplate reader market share in 2023.

South & Central America Microplate Reader Market Company Profiles

Hercuvan Lab Systems, Molecular Devices LLC, Thermo Fisher Scientific Inc, BMG LABTECH, Promega Corp, Revvity Inc, Bio-Rad Laboratories Inc, Tecan Trading AG, Lonza Group AG, and Agilent Technologies Inc. are some of the leading companies operating in the microplate reader market.

South & Central America Microplate Reader Market Strategic Insights

South & Central America Microplate Reader Market Segmentation Analysis

South & Central America Microplate Reader Market Report Highlights

South & Central America Microplate Reader Market Company Profiles

South & Central America Microplate Reader Market Country and Regional Insights